E-LIB Suche - Ergebnisse für: Banerjee, Subhashis

1

Deucravacitinib Long-Term Efficacy in Week 16 Placebo Cross..:

Lebwohl, Mark ; Warren, Richard B. ; Imafuku, Shinichi...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s365 , 2024

Link: https://doi.org/10.25251..

2

Deucravacitinib onset of action and maintenance of response..:

Korman, Neil J. ; Warren, Richard B. ; Bagel, Jerry...
Journal of Dermatological Treatment. 35 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

3

Structure–function analysis of nucleotide housekeeping prot..:

Saha, Debanjan ; Pramanik, Atanu ; Freville, Aline...
The FEBS Journal. , 2024

Link: https://doi.org/10.1111/..

4

Genetics of qualitative and quantitative traits in crosses ..:

Mukherjee, Debmala ; Mandal, Amit Ranjan ; Chatterjee, Subhrajyoti...
Crop Breeding and Applied Biotechnology. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1590/..

5

Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Bi..:

FitzGerald, Oliver ; Gladman, Dafna D. ; Mease, Philip J....
Arthritis & Rheumatology. , 2024

Link: https://doi.org/10.1002/..

6

Traceable mixnets:

Agrawal, Prashant ; Nakarmi, Abhinav ; Jhanwar, Mahabir Prasad..
Proceedings on Privacy Enhancing Technologies. 2024 (2024) 2 - p. 235-275 , 2024

Link: https://doi.org/10.56553..

7

Deucravacitinib Improves Patient-Reported Outcomes in Patie..:

Armstrong, April W. ; Augustin, Matthias ; Beaumont, Jennifer L....
Dermatology and Therapy. , 2024

Link: https://doi.org/10.1007/..

8

Efficacy of Deucravacitinib, an Oral, Selective, Allosteric..:

Blauvelt, Andrew ; Sofen, Howard ; Lambert, Jo...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 4 - p. s405 , 2024

Link: https://doi.org/10.25251..

9

Plasmodium falciparum Alba6 exhibits DNase activity and par..:

Nag, Shiladitya ; Banerjee, Chinmoy ; Goyal, Manish...
iScience. 27 (2024) 4 - p. 109467 , 2024

Link: https://doi.org/10.1016/..

10

Deucravacitinib in Plaque Psoriasis: Maintenance of Respons..:

Strober, Bruce ; Imafuku, Shinichi ; Paul, Carle...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 4 - p. s407 , 2024

Link: https://doi.org/10.25251..

11

Deucravacitinib in Plaque Psoriasis: 4-Year Safety and Effi..:

Armstrong, April W. ; Lebwohl, Mark ; Warren, Richard B....
SKIN The Journal of Cutaneous Medicine. 8 (2024) 4 - p. s406 , 2024

Link: https://doi.org/10.25251..

12

Plain Language Summary of the PAISLEY study: deucravacitini..:

Morand, Eric F. ; Pike, Marilyn ; Merrill, J...
Expert Opinion on Investigational Drugs. 33 (2024) 5 - p. 431-440 , 2024

Link: https://doi.org/10.1080/..

13

Deucravacitinib, a selective, allosteric tyrosine kinase 2 ..:

Blauvelt, Andrew ; Rich, Phoebe ; Sofen, Howard...
Journal of the American Academy of Dermatology. 90 (2024) 4 - p. 775-782 , 2024

Link: https://doi.org/10.1016/..

14

NSAID targets SIRT3 to trigger mitochondrial dysfunction an..:

Debsharma, Subhashis ; Pramanik, Saikat ; Bindu, Samik...
iScience. 27 (2024) 4 - p. 109384 , 2024

Link: https://doi.org/10.1016/..

15

On Managing Test-Time, Power, and Layer Assignment in 3D So..:

, In: 2024 37th International Conference on VLSI Design and 2024 23rd International Conference on Embedded Systems (VLSID),

Banerjee, Sabyasachee ; Majumder, Subhashis ; Bhattacharya, Bhargab B. - p. 684-689 , 2024

Link: https://doi.org/10.1109/..